Assembly Biosciences Inc. (ASMB)

36.55 -0.17 (-0.463%)

IEX Real-Time Price

August 17, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 36.72

Price Open 36.6

Volume: 223,211

Avg Volume: 303,277

Market Cap: 930.07M

P/E Ratio -12.31

52 Wk Range 24.74-67.36



ASMB Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
23.7M
428,692
1.29
1.81%

2018-07-13
23.4M
597,976
1.86
2.55%

2018-06-29
18.8M
834,409
3.86
4.44%

2018-06-15
18.8M
684,269
3.72
3.64%




ASMB Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-14
Q1 2018
N/A
-0.76 (3)
-0.16
0.00

2018-05-07
Q1 2018
N/A
-0.76 (3)
-0.80
-0.04

2018-04-05
Q4 2017
N/A
-0.79 (3)
-0.16
0.00

2018-03-29
Q4 2017
N/A
-0.79 (3)
-0.16
0.00

News

Assembly Biosciences misses by $0.44, misses on revenue (2018-08-08 17:09 SeekingAlpha)

Assembly Biosciences (NASDAQ: ASMB ): Q2 EPS of -$1.30 misses by $0.44 . More news on: Assembly Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, Read more …

 


Statistics

Shares Outstanding: 25.45M

Top 15 Institution Percent: 69.00

Price To Sales: 73.24

Price To Book: 10.44

Revenue: 2.66M

Gross Profit: N/A

Cash: 66.30M

Debt: N/A

Return On Assets: -43.99

Return On Equity: -80.11

Profit Margin: N/A

Price History

Beta: 0.88

50-day Moving Avg: 41.88

200-day Moving Avg: 44.95

YTD Change: -21.02

5-day Change: -7.52

1-month Change: -16.07

3-month Change: -14.06

6-month Change: -34.57

1-year Change: 48.70

Revenue Per Share: 0.00

Revenue Per Employee: 31290.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Assembly Biosciences Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.assemblybio.com

Assembly Biosciences Inc is a clinical stage biotechnology company advancing two innovative platform programs, a new class of oral therapeutics for the treatment of hepatitis B virus infection and novel class of oral synthetic live biotherapeutics.